- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有30家主力机构披露2025-12-31报告期持股数据，持仓量总计7203.29万股，占流通A股70.18%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了69%的股票
技术面评分前10的股票
近期的平均成本为25.39元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为25.39元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"25.39","date":1777191283,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.04.27","stock":"-2.70","trade":"-0.18","ind":"0.37"},{"date":"2026.04.24","stock":"1.68","trade":"-0.04","ind":"-0.69"},{"date":"2026.04.23","stock":"-1.76","trade":"-0.87","ind":"-0.88"},{"date":"2026.04.22","stock":"0.11","trade":"0.13","ind":"1.30"},{"date":"2026.04.21","stock":"-0.52","trade":"-0.57","ind":"0.10"},{"date":"2026.04.20","stock":"1.63","trade":"0.15","ind":"0.55"},{"date":"2026.04.17","stock":"-1.27","trade":"-1.52","ind":"0.60"},{"date":"2026.04.16","stock":"0.68","trade":"-0.13","ind":"2.05"},{"date":"2026.04.15","stock":"1.57","trade":"2.03","ind":"-0.97"},{"date":"2026.04.14","stock":"-0.11","trade":"0.36","ind":"1.61"},{"date":"2026.04.13","stock":"-1.21","trade":"-1.82","ind":"0.69"},{"date":"2026.04.10","stock":"1.49","trade":"0.01","ind":"2.24"},{"date":"2026.04.09","stock":"-3.05","trade":"-1.54","ind":"-0.33"},{"date":"2026.04.08","stock":"2.12","trade":"0.62","ind":"4.79"},{"date":"2026.04.07","stock":"2.93","trade":"0.87","ind":"0.36"},{"date":"2026.04.03","stock":"-2.96","trade":"-2.39","ind":"-0.99"},{"date":"2026.04.02","stock":"-1.05","trade":"0.62","ind":"-1.60"},{"date":"2026.04.01","stock":"2.97","trade":"2.36","ind":"1.70"},{"date":"2026.03.31","stock":"-1.56","trade":"-0.69","ind":"-1.81"},{"date":"2026.03.30","stock":"0.88","trade":"1.18","ind":"-0.25"},{"date":"2026.03.27","stock":"3.21","trade":"2.53","ind":"1.13"}]
恩威医药,深证成指,中药指数
压力支撑
该股压力位为25.33元，支撑位为24.63元。
[{"text":"\u538b\u529b\u4f4d","value":"25.33","date":1777219200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"24.63","date":1777219200,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.0资金面打败了83%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月27日 20:31
| 机构今日流向(万元) | -355.97 | 机构5日流向(万元) | -4669.69 |
| 机构10日流向(万元) | -8709.65 | 机构20日流向(万元) | -15220.02 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加6968.35万股，其中基金净减仓2家，主力净增仓20家，请投资者中长期谨慎为宜。
截止2025-12-31，共30家主力机构（基金24家，一般法人6家），持仓量总计7203.29万股，占流通A股70.18%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：2家 ，减持 0.79万股
新出现在主力名单中：27家 ，持有7151.63万股
从主力名单中消失：7家 ，原持有182.49万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：2家 ，减持 0.79万股
新出现在主力名单中：27家 ，持有7151.63万股
从主力名单中消失：7家 ，原持有182.49万股
消息面诊股
诊断结果：6.4消息面打败了74%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 恩威医药：4月24日获融资买入284.18万元
2026-04-27 - 股东追踪|广发证券股份有限公司等新进恩威医药前十大
2026-04-26 - 恩威医药（截止2026年3月31日）股东人数为77
2026-04-26 - 恩威医药：4月23日获融资买入97.22万元
2026-04-24 - 恩威医药：4月22日获融资买入220.81万元
2026-04-23 - 恩威医药：4月21日获融资买入105.36万元
2026-04-22 - 恩威医药：控股股东成都恩威投资（集团）有限公司解除
2026-04-21 - 恩威医药：4月20日获融资买入212.54万元
2026-04-21 - 恩威医药：4月17日获融资买入138.48万元
2026-04-20 - 恩威医药：4月16日获融资买入146.93万元
2026-04-17
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-27 |
| 利好 | 分红转增 | 10派6.8元(含税) | 2026-04-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-16 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-02-02 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-01-20 |
| 利好 | 分红转增 | 10派3.5元(含税) | 2025-12-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-17 |
| 一般消息 | 高管变动 | 修订章程取消监事会 | 2025-05-12 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 1条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.5行业面打败了19%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.04.27","price":"0.37","value":"-0.18"},{"date":"2026.04.24","price":"-0.69","value":"-0.04"},{"date":"2026.04.23","price":"-0.88","value":"-0.87"},{"date":"2026.04.22","price":"1.30","value":"0.13"},{"date":"2026.04.21","price":"0.10","value":"-0.57"},{"date":"2026.04.20","price":"0.55","value":"0.15"},{"date":"2026.04.17","price":"0.60","value":"-1.52"},{"date":"2026.04.16","price":"2.05","value":"-0.13"},{"date":"2026.04.15","price":"-0.97","value":"2.03"},{"date":"2026.04.14","price":"1.61","value":"0.36"},{"date":"2026.04.13","price":"0.69","value":"-1.82"},{"date":"2026.04.10","price":"2.24","value":"0.01"},{"date":"2026.04.09","price":"-0.33","value":"-1.54"},{"date":"2026.04.08","price":"4.79","value":"0.62"},{"date":"2026.04.07","price":"0.36","value":"0.87"},{"date":"2026.04.03","price":"-0.99","value":"-2.39"},{"date":"2026.04.02","price":"-1.60","value":"0.62"},{"date":"2026.04.01","price":"1.70","value":"2.36"},{"date":"2026.03.31","price":"-1.81","value":"-0.69"},{"date":"2026.03.30","price":"-0.25","value":"1.18"},{"date":"2026.03.27","price":"1.13","value":"2.53"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康惠股份 | 23.30% | 2.61% | 5.8分 |
| 2 | 沃华医药 | 17.95% | -2.73% | 5.8分 |
| 3 | 万邦德 | 14.44% | 3.51% | 6.3分 |
| 4 | 益佰制药 | 10.42% | -7.42% | 4.5分 |
| 5 | 九芝堂 | 5.86% | 4.86% | 6.5分 |
| 6 | 康缘药业 | 5.58% | 2.45% | 5.9分 |
| 8 | 亚宝药业 | 4.30% | 2.26% | 6.4分 |
| 10 | 众生药业 | 4.05% | 5.99% | 6.2分 |
| 12 | ST百灵 | 2.90% | -3.12% | 4.7分 |
| 14 | 千金药业 | 2.32% | 0.95% | 6.2分 |
| 16 | 康恩贝 | 2.07% | -5.74% | 5.1分 |
| 18 | 华森制药 | 1.96% | -0.99% | 5.4分 |
| 20 | 以岭药业 | 1.51% | 1.39% | 5.2分 |
| 22 | 益盛药业 | 1.36% | 6.38% | 6.2分 |
| 24 | ST香雪 | 0.85% | -7.95% | 3.7分 |
| 26 | 精华制药 | 0.41% | -1.62% | 5.5分 |
| 28 | 云南白药 | -0.20% | -1.29% | 6.2分 |
| 30 | 恩威医药 | -0.46% | -3.21% | 6.0分 |
| 32 | 步长制药 | -0.61% | -2.64% | 5.5分 |
| 34 | 汉森制药 | -0.92% | -1.37% | 5.4分 |
| 36 | 太龙药业 | -1.13% | -1.54% | 5.3分 |
| 38 | 桂林三金 | -1.55% | -0.99% | 5.8分 |
| 40 | 华神科技 | -1.97% | -1.24% | 5.7分 |
| 42 | 中恒集团 | -2.39% | -2.39% | 4.6分 |
| 44 | 方盛制药 | -2.71% | 4.35% | 6.7分 |
| 46 | 白云山 | -2.92% | -2.02% | 5.1分 |
| 48 | 上海凯宝 | -3.21% | -4.34% | 4.7分 |
| 50 | 同仁堂 | -3.39% | -1.48% | 5.1分 |
| 52 | 红日药业 | -3.74% | -5.37% | 4.8分 |
| 54 | 新天药业 | -4.29% | -0.93% | 5.3分 |
| 56 | 维康药业 | -5.19% | -3.59% | 4.7分 |
| 58 | 珍宝岛 | -5.82% | -0.60% | 4.8分 |
| 60 | 华润三九 | -7.05% | -5.63% | 5.6分 |
| 62 | 片仔癀 | -8.25% | -3.29% | 4.3分 |
| 64 | 盘龙药业 | -8.42% | -3.71% | 4.8分 |
| 66 | 昆药集团 | -13.51% | -11.57% | 5.1分 |
| 68 | 嘉应制药 | -15.51% | -16.16% | 5.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-12-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 27/107 ， 27/107。
[{"date":"2025-12-31","value":"4.88","vol":"5.17"},{"date":"2025-09-30","value":"3.42","vol":"4.81"},{"date":"2025-06-30","value":"3.58","vol":"4.04"},{"date":"2025-03-31","value":"1.53","vol":"2.25"},{"date":"2024-12-31","value":"3.47","vol":"4.87"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.88 | 3.42 | 3.58 | 1.53 | 3.47 |
| 行业(%) | 5.17 | 4.81 | 4.04 | 2.25 | 4.87 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"49.51","vol":"52.40"},{"date":"2025-09-30","value":"48.22","vol":"53.26"},{"date":"2025-06-30","value":"49.10","vol":"53.79"},{"date":"2025-03-31","value":"48.13","vol":"54.43"},{"date":"2024-12-31","value":"50.82","vol":"53.69"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.51 | 48.22 | 49.10 | 48.13 | 50.82 |
| 行业(%) | 52.40 | 53.26 | 53.79 | 54.43 | 53.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/107 ， 8/107。
[{"date":"2025-12-31","value":"10.91","vol":"-5.67"},{"date":"2025-09-30","value":"13.65","vol":"-7.81"},{"date":"2025-06-30","value":"15.73","vol":"-7.74"},{"date":"2025-03-31","value":"7.10","vol":"-7.31"},{"date":"2024-12-31","value":"3.43","vol":"-6.13"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
10.91 | 13.65 | 15.73 | 7.10 | 3.43 |
| 行业(%) | -5.67 | -7.81 | -7.74 | -7.31 | -6.13 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"38.53","vol":"-91.01"},{"date":"2025-09-30","value":"66.13","vol":"-2.50"},{"date":"2025-06-30","value":"113.80","vol":"2.58"},{"date":"2025-03-31","value":"93.56","vol":"-37.35"},{"date":"2024-12-31","value":"-56.56","vol":"-148.45"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
38.53 | 66.13 | 113.80 | 93.56 | -56.56 |
| 行业(%) | -91.01 | -2.50 | 2.58 | -37.35 | -148.45 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/107 ， 7/107。
[{"date":"2025-12-31","value":"0.59","vol":"0.50"},{"date":"2025-09-30","value":"0.42","vol":"0.35"},{"date":"2025-06-30","value":"0.30","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.13"},{"date":"2024-12-31","value":"0.57","vol":"0.50"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.59 | 0.42 | 0.30 | 0.13 | 0.57 |
| 行业(次) | 0.50 | 0.35 | 0.24 | 0.13 | 0.50 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"4.20","vol":"2.42"},{"date":"2025-09-30","value":"2.87","vol":"1.72"},{"date":"2025-06-30","value":"2.00","vol":"1.17"},{"date":"2025-03-31","value":"0.88","vol":"0.60"},{"date":"2024-12-31","value":"3.58","vol":"2.41"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
4.20 | 2.87 | 2.00 | 0.88 | 3.58 |
| 行业(次) | 2.42 | 1.72 | 1.17 | 0.60 | 2.41 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/107 ， 32/107。
[{"date":"2025-12-31","value":"12.65","vol":"21.97"},{"date":"2025-09-30","value":"0.54","vol":"10.53"},{"date":"2025-06-30","value":"19.98","vol":"22.82"},{"date":"2025-03-31","value":"12.56","vol":"2.07"},{"date":"2024-12-31","value":"2.96","vol":"22.07"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 12.65 | 0.54 | 19.98 | 12.56 | 2.96 |
| 行业 | 21.97 | 10.53 | 22.82 | 2.07 | 22.07 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"1.08","vol":"0.81"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.34","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.95","vol":"1.48"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.08 | - | 1.34 | - | 0.95 |
| 行业 | 0.81 | 0.00 | 1.03 | 0.00 | 1.48 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/107 ， 26/107。
[{"date":"2025-12-31","value":"2.14","vol":"2.85"},{"date":"2025-09-30","value":"4.44","vol":"3.09"},{"date":"2025-06-30","value":"4.11","vol":"2.94"},{"date":"2025-03-31","value":"4.43","vol":"3.03"},{"date":"2024-12-31","value":"3.99","vol":"2.92"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.14 | 4.44 | 4.11 | 4.43 | 3.99 |
| 行业 | 2.85 | 3.09 | 2.94 | 3.03 | 2.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"1.86","vol":"2.19"},{"date":"2025-09-30","value":"3.76","vol":"2.24"},{"date":"2025-06-30","value":"3.53","vol":"2.15"},{"date":"2025-03-31","value":"3.75","vol":"2.24"},{"date":"2024-12-31","value":"3.42","vol":"2.13"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.86 | 3.76 | 3.53 | 3.75 | 3.42 |
| 行业 | 2.19 | 2.24 | 2.15 | 2.24 | 2.13 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/107 ， 23/107。
[{"date":"2025-12-31","value":"30.82","vol":"32.03"},{"date":"2025-09-30","value":"27.60","vol":"31.59"},{"date":"2025-06-30","value":"28.57","vol":"32.44"},{"date":"2025-03-31","value":"28.05","vol":"31.90"},{"date":"2024-12-31","value":"29.70","vol":"32.73"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
30.82 | 27.60 | 28.57 | 28.05 | 29.70 |
| 行业(%) | 32.03 | 31.59 | 32.44 | 31.90 | 32.73 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.45","vol":"0.68"},{"date":"2025-09-30","value":"0.38","vol":"0.76"},{"date":"2025-06-30","value":"0.40","vol":"0.75"},{"date":"2025-03-31","value":"0.39","vol":"0.74"},{"date":"2024-12-31","value":"0.42","vol":"0.76"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.45 | 0.38 | 0.40 | 0.39 | 0.42 |
| 行业(%) | 0.68 | 0.76 | 0.75 | 0.74 | 0.76 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.37","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.52","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]